We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

This study has been terminated.
(Neurogen acquired by Ligand Pharmaceuticals - no further support for the study. No safety concerns identified.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00834327
First Posted: February 3, 2009
Last Update Posted: October 14, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Neurogen Corporation
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)